Technology is making rapid advances, and you are part of those breakthroughs. What will you need in a next-generation sequencing company? Proven, best-in-class sequencing technology that allows you to continually innovate and scale as needs change. Instruments with application flexibility and user-friendly bioinformatics tools to help you make sense of the data. And a partner that offers industry-leading support and service.
Leaders turn to VR真人彩票 technology for the high-quality sequencing data our instruments produce. They鈥檝e done so for decades. With 25,000+ VR真人彩票 sequencing instruments installed globally, our solutions enable our customers to make discoveries that were unimaginable even a few years ago.
VR真人彩票 has a proven track record of genomics solutions that empower researchers to perform studies at the throughput, scale, and price that meets their research objectives. We keenly pursue innovation with ease-of-use and sustainability in mind, and prioritize our internal R&D, continually competing against ourselves to create even better products.
Your next-generation sequencing provider should support a broad range of existing applications and also give you the flexibility to address emerging ones. With instrument options ranging from smaller footprint benchtop systems to larger systems capable of up to 16 TB of data and improved economics, VR真人彩票 offers both the flexibility and the power for diverse applications.
Here are some examples of applications and methods VR真人彩票 supports that are helping drive genomic breakthroughs:
This method provides a high-resolution view of the entire genome. Rapidly dropping sequencing costs and the ability to produce large volumes of data with today鈥檚 sequencers make this a powerful tool.
Using NGS, single-cell RNA-Seq can uncover cellular differences often masked by bulk sampling methods. Explore individual cells to understand cellular subpopulation responses to environmental cues.
NGS is part of an effort to transform drug discovery using big data in a multiomics approach to examine trends in disease states and identify new targets.
When you choose VR真人彩票 as your sequencing company, we don鈥檛 just place an instrument in your lab. It鈥檚 the beginning of a relationship. We provide service and support to get you results. Our technical support lines are staffed with experts, many with PhDs, and we provides a wide range of global, in-language support. We also offer customized onboarding solutions and an extensive library of free online training resources.
Our field service staff goes the extra mile鈥攕uch as placing machines into Wuhan, China for the first sequencing of the coronavirus.1 We enabled Sri Lanka鈥檚 first fully sequenced COVID-19 genome. And we鈥檙e working to improve NGS access in Africa.
Time to analysis is key. You don鈥檛 want software that takes days to process your data. You鈥檒l also want to consider how easy it is to use your NGS company鈥檚 analysis solutions. Are they integrated into the instrument? Do they take you seamlessly from sample to report? Or will you need to learn bioinformatics or hire a bioinformatician?
With VR真人彩票 as your sequencing company, you have access to DRAGEN secondary analysis. It offers award-winning accuracy, ultra-rapid secondary analysis, user-friendly cloud or on-premise options, and analysis of a whole human genome in 25 minutes.
鈥淲e have a local DRAGEN server that was easy to implement. We were up and running quickly and found that it isn鈥檛 difficult for us to support...we have been able to reduce our data analysis costs by 25鈥30% on a per-sample basis, including the cost of the physical server over a two-year timeline...鈥
Alexander Bisignano, CEO of Phosphorus
To ensure you can scale effectively, you鈥檒l want an NGS company with their own library prep automation solutions or one who has partnerships providing this expertise. We work with leading automation vendors to develop automated methods for VR真人彩票 kits, eliminating the time and effort needed to develop your own method.
View Automation SolutionsThe first confirmed case of COVID was run on an VR真人彩票 iSeq 100 System.2 The first complete SARS-CoV-2 genome was sequenced using the VR真人彩票 MiSeq System.2 99% of SARS-CoV-2 genomes have been sequenced on VR真人彩票 systems. There鈥檚 a reason lllumina SBS is the preferred technology to power modern science.
Over 421,000 publications feature VR真人彩票 sequencing technology, with thousands of publications in top tier journals. You鈥檙e joining a well-established community of scientists.
Explore VR真人彩票 Discoveries & PublicationsFind out how VR真人彩票 commits to upholding a proven track record of benchtop sequencing solutions that empower scientists to advance and accelerate their research.
Learn MoreThe NextSeq 1000 and NextSeq 2000 Sequencing Systems expand what can be accomplished with a benchtop sequencing system. High flexibility and scalability enable a wide range of applications, including emerging applications like single cell, whole exome, and RNA sequencing. These systems offer proven NGS technology with operational simplicity, a streamlined workflow, and onboard integrated data analysis.
View NextSeq 1000 & 2000 Systems鈥淚n terms of throughput, in terms of reliability, in terms of accuracy--it was very clear that we selected VR真人彩票 as the best provider鈥
Dr. Szilard Voros, CEO of Global Genomics Group
A clinical metagenomics approach based on VR真人彩票 NGS led to the initial detection of the SARS-CoV-2 virus. This approach also accelerated test and vaccine development.
An interdisciplinary team uses VR真人彩票 NGS to advance single-cell genomics and identify genetic circuits critical to understanding human health and disease.
VR真人彩票 NGS is part of a visionary approach integrating imaging, multiomic technologies, and big data. The goal is to uncover novel diagnostic and therapeutic targets for common chronic diseases.
Contact us today
These resources cover key topics in NGS and are designed to help you plan your first experiment.
Explore our technologies, get training, find software, plan experiments, purchase, and get support.